A recent study showed that in pancreatic ductal adenocarcinoma (PDAC), activated GLS increased glutamine catabolism and production of nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione, which prevented from being oxidative and promoting tumor cell survival and tumor growth in mice (31). This evidence concerns the gene GLS and pancreatic ductal adenocarcinoma.